The Patent Finder

Innocrin Pharmaceuticals Inc

Also on record
Records under this name other than patents Innocrin Pharmaceuticals Inc holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Innocrin Pharmaceuticals Inc

PatentTitleStatus Expires Confidence
US 8,389,543Metalloenzyme Inhibitor Compounds
In force
 · High confidence
In forceHigh confidence
US 8,623,892Metalloenzyme Inhibitor Compounds
In force
 · High confidence
In forceHigh confidence
US 11,980,626Compositions for Treatment of Breast and Prostate Cancer
In force
 · High confidence
In forceHigh confidence
US 9,056,855Metalloenzyme Inhibitor Compounds
Lapsed on the fee record
Ended Jun 16, 2023 · High confidence
Lapsed on the fee recordEnded Jun 16, 2023High confidence
US 8,987,315Metalloenzyme Inhibitor Compounds
Lapsed on the fee record
Ended Mar 24, 2023 · High confidence
Lapsed on the fee recordEnded Mar 24, 2023High confidence
US 8,669,274Metalloenzyme Inhibitor Compounds
Lapsed on the fee record
Ended Mar 11, 2022 · High confidence
Lapsed on the fee recordEnded Mar 11, 2022High confidence
US 9,150,527Metalloenzyme Inhibitor Compounds
Lapsed on the fee record
Ended Oct 6, 2019 · High confidence
Lapsed on the fee recordEnded Oct 6, 2019High confidence
14/148,318Metalloenzyme Inhibitor Compounds
Abandoned
Abandoned Oct 17, 2017
AbandonedAbandoned Oct 17, 2017
15/423,235Metalloenzyme Inhibitor Compounds
Abandoned
Abandoned Jun 4, 2018
AbandonedAbandoned Jun 4, 2018
15/944,397Metalloenzyme Inhibitor Compounds
Abandoned
Abandoned Apr 23, 2019
AbandonedAbandoned Apr 23, 2019
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited